Showing results (581-590 of 1,050) with videos related to
Sort By:
Pageof 105
Clinical Kidney Journal|February 5, 2024
Comparison of three creatinine-based equations to predict adverse outcome in a cardiovascular high-risk cohort: an investigation using the SPRINT research materialsInsa E Emrich, John W Pickering, Felix Götzinger, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 8, 2024
Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registryTobias Heer, Uwe Zeymer, Matthias Hochadel, et al.Journal of the American College of Cardiology|February 25, 2012
Update on myocarditisIngrid Kindermann, Christine Barth, Felix Mahfoud, et al.Journal of the American College of Cardiology|December 10, 2013
Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reductionStephan H Schirmer, Marwa M Y A Sayed, Jan-Christian Reil, et al.The Journal of Nutritional Biochemistry|August 1, 2017
Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cellsCristina Perez-Ternero, Christian M Werner, Alexander G Nickel, et al.Journal of Hypertension|December 2, 2016
Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY RegistryDominik Linz, Giuseppe Mancia, Felix Mahfoud, et al.Clinical Drug Investigation|July 20, 2007
Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST StudyVivencio Barrios, Alessandro Boccanelli, Silke Ewald, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|May 9, 2017
Improvement in health-related quality of life after renal sympathetic denervation in real-world hypertensive patients: 12-month outcomes in the Global SYMPLICITY RegistryIngrid Kindermann, Sonja Maria Wedegärtner, Felix Mahfoud, et al.Biochemical and Biophysical Research Communications|May 25, 2010
Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophyStephanie I Bettink, Christian Werner, Chia-Hui Chen, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 14, 2016
Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studiesDominik Linz, Henrik Fox, Thomas Bitter, et al.Pageof 105